Gt biopharma submits application for uplisting to the nasdaq capital market

Beverly hills, calif., dec. 14, 2020 /prnewswire/ -- gt biopharma, inc. (otcqb: gtbp) (gtbp.pa) an immuno-oncology company focused on innovative therapies based on the company's proprietary nk cell engager (trike™) technology platform today announced that it has submitted an application...

GTBP Ratings Summary

GTBP Quant Ranking